Drug Name: Pombiliti
Active Ingredient: cipaglucosidase alfa-atga
Indications: To treat late-onset Pompe disease
Approval Date: 9/28/2023
Company: Amicus Therapeutics, Inc.
More: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761204s000lbl.pdf